drugset
drugset / Trial / NCT02970630

Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study

NCT02970630 ↗

Phase 2 Completed 28 enrolled Chiesi Farmaceutici S.p.A. Cromsource · collab
NaSingle-groupOpen-labelTreatment

Summary

Prospective, single-arm, open-label, multicentre study with the principal aim to estimate tacrolimus pharmacokinetic parameters in elderly de-novo kidney transplant recipients of ECD (Extended Criteria Donor) kidney grafts treated with Envarsus® prolonged release tablets in combination with everolimus tablets.

Timeline

Start
2017-01
Primary completion
2018-02-22
Completion
2018-02-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 0.07 mg/kg —
Background Everolimus Small molecule 1 mg —

Indications

No indication recorded.